Email this article Hormonal contraception for women with type 1 diabetes
- Authors: Ailamazyan E.K.1, Nikitin S.V.1, Potin V.V.1
-
Affiliations:
- Research Institute of Obstetrics and Gynecology named after D.O. Otta RAMS
- Issue: Vol 50, No 4 (2001)
- Pages: 8-13
- Section: Current public health problems
- URL: https://journals.eco-vector.com/jowd/article/view/95614
- DOI: https://doi.org/10.17816/JOWD95614
- ID: 95614
Cite item
Open Access
Access granted
Abstract
The investigation demonstrates the influence ofperoral combined contraceptives and preparations containing only progestagens on carbohydrate and lipid exchange and haemostatic system. The factors, which exert influence upon metabolic indices in women with type I insular diabetes, are estimated. The correlation between the intake of combined and containing only progestagens contraceptive preparations and the risk of tromboembolism is revealed. The indications and contraindications are defined for the prescription of peroral contraceptives in women with type I insular diabetes.
Keywords
Full Text
About the authors
E. K. Ailamazyan
Research Institute of Obstetrics and Gynecology named after D.O. Otta RAMS
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Saint Petersburg
S. V. Nikitin
Research Institute of Obstetrics and Gynecology named after D.O. Otta RAMS
Email: info@eco-vector.com
Russian Federation, Saint Petersburg
V. V. Potin
Research Institute of Obstetrics and Gynecology named after D.O. Otta RAMS
Email: info@eco-vector.com
Russian Federation, Saint Petersburg
References
